HEALTH – Alloftop.com https://www.alloftop.com Top Stories in Tech, Business & Beyond Sat, 04 Apr 2026 11:30:44 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://www.alloftop.com/wp-content/uploads/2024/09/alloftop.com_-e1726901469505-80x80.png HEALTH – Alloftop.com https://www.alloftop.com 32 32 2026 Cholesterol Guidelines: Lower LDL Targets, Earlier Screenings, and 33% Fewer Heart Events in New Study https://www.alloftop.com/2026-cholesterol-guidelines-lower-ldl-targets-earlier-screenings-and-33-fewer-heart-events-in-new-study/ Sat, 04 Apr 2026 11:30:44 +0000 https://www.alloftop.com/2026-cholesterol-guidelines-lower-ldl-targets-earlier-screenings-and-33-fewer-heart-events-in-new-study/ New cholesterol guidelines for 2026 recommend earlier screenings and aggressive LDL lowering. Recent studies show a 33% reduction in heart events when LDL is brought below 55 mg/dL.

The post 2026 Cholesterol Guidelines: Lower LDL Targets, Earlier Screenings, and 33% Fewer Heart Events in New Study appeared first on Alloftop.com.

]]> Nearly 33% of Indian Fever Patients Diagnosed With Serious Infections in 2026, Study Finds https://www.alloftop.com/nearly-33-of-indian-fever-patients-diagnosed-with-serious-infections-in-2026-study-finds/ Sat, 28 Mar 2026 11:31:26 +0000 https://www.alloftop.com/nearly-33-of-indian-fever-patients-diagnosed-with-serious-infections-in-2026-study-finds/ A new study reveals that almost one in three Indians with fever are diagnosed with serious infections like typhoid, dengue, and malaria, highlighting urgent needs for timely testing and intervention.

The post Nearly 33% of Indian Fever Patients Diagnosed With Serious Infections in 2026, Study Finds appeared first on Alloftop.com.

]]> Python Blood Molecule Rises 1,000-Fold After Feeding, Suppresses Appetite and Promotes Weight Loss in Mice Without GLP-1 Drug Side Effects https://www.alloftop.com/python-blood-molecule-rises-1000-fold-after-feeding-suppresses-appetite-and-promotes-weight-loss-in-mice-without-glp-1-drug-side-effects/ Sat, 21 Mar 2026 11:30:50 +0000 https://www.alloftop.com/python-blood-molecule-rises-1000-fold-after-feeding-suppresses-appetite-and-promotes-weight-loss-in-mice-without-glp-1-drug-side-effects/ A newly discovered molecule in python blood, para-tyramine-O-sulfate (pTOS), surges 1,000 times post-feeding and suppresses appetite in mice, pointing to a promising new path for weight loss drugs without the nausea or muscle loss linked to GLP-1 drugs.

The post Python Blood Molecule Rises 1,000-Fold After Feeding, Suppresses Appetite and Promotes Weight Loss in Mice Without GLP-1 Drug Side Effects appeared first on Alloftop.com.

]]> FDA Panel Unanimously Recommends Reformulated 2026–2027 Flu Vaccine to Target Subclade K Amid Low Effectiveness Rates https://www.alloftop.com/fda-panel-unanimously-recommends-reformulated-2026-2027-flu-vaccine-to-target-subclade-k-amid-low-effectiveness-rates/ Sat, 14 Mar 2026 11:30:46 +0000 https://www.alloftop.com/fda-panel-unanimously-recommends-reformulated-2026-2027-flu-vaccine-to-target-subclade-k-amid-low-effectiveness-rates/ A new FDA panel vote means next season’s flu vaccine will target the fast-spreading subclade K, after this year’s shot protected only 22–34% of adults.

The post FDA Panel Unanimously Recommends Reformulated 2026–2027 Flu Vaccine to Target Subclade K Amid Low Effectiveness Rates appeared first on Alloftop.com.

]]> Cardiorespiratory Fitness Linked to Lower COVID-19 Hospitalization Risk in Major Norwegian Study of 48,821 Adults https://www.alloftop.com/cardiorespiratory-fitness-linked-to-lower-covid-19-hospitalization-risk-in-major-norwegian-study-of-48821-adults/ Sat, 07 Mar 2026 17:54:00 +0000 https://www.alloftop.com/cardiorespiratory-fitness-linked-to-lower-covid-19-hospitalization-risk-in-major-norwegian-study-of-48821-adults/ A major Norwegian study found that higher cardiorespiratory fitness significantly reduced the risk of COVID-19–related hospitalization, but did not affect the chance of contracting the virus.

The post Cardiorespiratory Fitness Linked to Lower COVID-19 Hospitalization Risk in Major Norwegian Study of 48,821 Adults appeared first on Alloftop.com.

]]> India Launches Free Nationwide HPV Vaccination Drive for 1.15 Crore 14-Year-Old Girls From Feb 28, 2026 https://www.alloftop.com/india-launches-free-nationwide-hpv-vaccination-drive-for-1-15-crore-14-year-old-girls-from-feb-28-2026/ Sat, 28 Feb 2026 11:31:22 +0000 https://www.alloftop.com/india-launches-free-nationwide-hpv-vaccination-drive-for-1-15-crore-14-year-old-girls-from-feb-28-2026/ India has launched a free, nationwide campaign to vaccinate 1.15 crore 14-year-old girls against HPV, aiming to curb cervical cancer deaths using the Gardasil 4 vaccine.

The post India Launches Free Nationwide HPV Vaccination Drive for 1.15 Crore 14-Year-Old Girls From Feb 28, 2026 appeared first on Alloftop.com.

]]> India Launches Indigenous Td Vaccine: 55 Lakh Doses to Be Supplied by April 2026, Prices Set to Drop https://www.alloftop.com/india-launches-indigenous-td-vaccine-55-lakh-doses-to-be-supplied-by-april-2026-prices-set-to-drop/ Sat, 21 Feb 2026 11:31:07 +0000 https://www.alloftop.com/india-launches-indigenous-td-vaccine-55-lakh-doses-to-be-supplied-by-april-2026-prices-set-to-drop/ India has launched its first indigenously manufactured Tetanus and adult Diphtheria (Td) vaccine at the Central Research Institute in Kasauli, Himachal Pradesh. The move replaces the old tetanus toxoid shot, will supply 55 lakh doses by April 2026, and is expected to lower vaccine costs under the Universal Immunization Programme.

The post India Launches Indigenous Td Vaccine: 55 Lakh Doses to Be Supplied by April 2026, Prices Set to Drop appeared first on Alloftop.com.

]]> FDA Approves Widaplik Quadpill for Hypertension as 50% of Patients Fail to Stick to Multi-Drug Regimens https://www.alloftop.com/fda-approves-widaplik-quadpill-for-hypertension-as-50-of-patients-fail-to-stick-to-multi-drug-regimens/ Sat, 14 Feb 2026 11:30:48 +0000 https://www.alloftop.com/fda-approves-widaplik-quadpill-for-hypertension-as-50-of-patients-fail-to-stick-to-multi-drug-regimens/ With up to half of hypertension patients struggling to take multiple daily medications, the FDA has approved Widaplik—a single-pill combination therapy—while new research highlights the benefits of "quadpill" strategies and even hot water immersion for managing high blood pressure.

The post FDA Approves Widaplik Quadpill for Hypertension as 50% of Patients Fail to Stick to Multi-Drug Regimens appeared first on Alloftop.com.

]]> AI-Assisted Mammography Cuts Interval Breast Cancer Diagnoses by 12% in 100,000-Woman Swedish Trial, Study Finds https://www.alloftop.com/ai-assisted-mammography-cuts-interval-breast-cancer-diagnoses-by-12-in-100000-woman-swedish-trial-study-finds/ Sat, 31 Jan 2026 11:30:52 +0000 https://www.alloftop.com/ai-assisted-mammography-cuts-interval-breast-cancer-diagnoses-by-12-in-100000-woman-swedish-trial-study-finds/ A landmark Swedish study of over 100,000 women shows AI-supported mammography reduces interval breast cancer diagnoses by 12%, detects more aggressive cancers earlier, and lowers radiologists’ workload by 44%.

The post AI-Assisted Mammography Cuts Interval Breast Cancer Diagnoses by 12% in 100,000-Woman Swedish Trial, Study Finds appeared first on Alloftop.com.

]]> Study Finds NETs-Based Risk Score Predicts Survival and Treatment Response in 146 Colorectal Cancer Patients https://www.alloftop.com/study-finds-nets-based-risk-score-predicts-survival-and-treatment-response-in-146-colorectal-cancer-patients/ Sat, 24 Jan 2026 11:30:47 +0000 https://www.alloftop.com/study-finds-nets-based-risk-score-predicts-survival-and-treatment-response-in-146-colorectal-cancer-patients/ New research shows that a risk model based on neutrophil extracellular traps (NETs) genes accurately predicts prognosis and chemotherapy response in colorectal cancer, offering hope for more personalized treatment strategies.

The post Study Finds NETs-Based Risk Score Predicts Survival and Treatment Response in 146 Colorectal Cancer Patients appeared first on Alloftop.com.

]]>